Maddrey Score

The Maddrey Score estimates short‑term mortality risk in alcoholic hepatitis to identify patients who may benefit from corticosteroid therapy.

mg/dLmcmol/L

适用指征

Indicated to assess severity of alcoholic hepatitis and identify candidates for corticosteroids when score ≥32, which reflects a 30–50% 28‑day mortality 1 [Level I evidence]. Used to separate severe from mild/moderate disease and predict short‑term prognosis, guiding whether to initiate prednisolone 2 [Level I evidence]. A value <32 suggests lower short‑term risk and need for supportive care alone.

洞见与注意事项

Identifies severe alcoholic hepatitis when markedly elevated values indicate ~30–50% 28‑day mortality and potential steroid benefit (AASLD guidance) 1. Caution: misses renal dysfunction, is inferior to MELD/ABIC/GAHS for prognostication (STOPAH; 1,068 pts) 2, varies with control PT, and offers poor long‑term prediction. High scores risk overtreatment; low scores are not benign.